Matrikynes® Clinical Study Published
The structure, function, and appearance of skin are all significantly improved by Matrikynes® from Xylyx Bio, according to a clinical study.
Results from independent clinical studies validate Matrikynesability ®’s to reverse common aging and skin damage symptoms, including the appearance of lines and wrinkles.
The results of an independent clinical study confirmed that the proprietary Matrikynes® ingredient used by Xylyx Bio, a regenerative medicine company developing ground-breaking technologies for organ and tissue repair, is both safe and highly effective for topical skin applications such as anti-aging.
Results from the study are reported in the white paper “Clinical evaluation of Matrikynes®: a novel cosmetic ingredient comprised of matrikine peptides“.
Developed through biomedical research aimed at better understanding and promoting tissue repair and wound healing, Matrikynes® is comprised of a proprietary mixture of natural extracellular matrix-derived peptides called matrikines.
The intrinsic bioactivity of matrikines has been shown to activate regenerative mechanisms that can drive tissue repair and reverse the effects of aging.
56 female volunteers between the ages of 35 and 65 who represented a variety of skin types and tones participated in the independent study to assess the clinical safety and effectiveness of Matrikynes® for topical skin applications.
Utilizing clinical instrumentation and approved measurement methods, standard dermatological evaluations were carried out. The structure, function, and appearance of aging and damaged skin improved in numerous statistically significant ways after topical application of Matrikynes®.
KEY CLINICAL STUDY FINDINGS INCLUDE
• Safety testing showed no allergic sensitization or irritant reaction to Matrikynes®
• Topical application of Matrikynes® significantly improved skin barrier repair
• Topical application of Matrikynes® increased skin density and decreased the appearance of global fines lines and deep wrinkles
Dr. John O’Neill, Chief Scientific Officer of Xylyx Bio, stated, “As a pioneer in regenerative medicine, Xylyx Bio developed Matrikynes® in response to the increasing demand in topical skincare for evidence-based ingredients that can effectively address skin damage and aging.
This study confirms that Matrikynes® is safe and offers multiple functional and cosmetic benefits. Such significant reparative capabilities in a single ingredient pave the way for a new paradigm of regenerative skincare.”
